Advertisement
Screener

PROMETHEUS BIOSCIENCES, INC. Capital Expenditures

PROMETHEUS BIOSCIENCES, INC. Capital Expenditures

PROMETHEUS BIOSCIENCES, INC. reported Capital Expenditures of $530.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-09.

Discontinued › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2023-05-09

  • PROMETHEUS BIOSCIENCES, INC. payments to acquire property, plant, and equipment for the quarter ending 2023-03-31 was $530.00K, a 44.50% decline year-over-year.
  • PROMETHEUS BIOSCIENCES, INC. payments to acquire property, plant, and equipment for the quarter ending 2022-12-31 was $369.00K, a 94.21% increase year-over-year.
  • PROMETHEUS BIOSCIENCES, INC. payments to acquire property, plant, and equipment for the quarter ending 2022-09-30 was $491.00K, a 34.15% increase year-over-year.
  • PROMETHEUS BIOSCIENCES, INC. payments to acquire property, plant, and equipment for the quarter ending 2022-06-30 was $888.00K, a 214.89% increase year-over-year.
  • PROMETHEUS BIOSCIENCES, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $2.70M, a 137.94% increase from fiscal 2021.
  • PROMETHEUS BIOSCIENCES, INC. payments to acquire property, plant, and equipment for fiscal 2021 was $1.14M, a 456.86% increase from fiscal 2020.
  • PROMETHEUS BIOSCIENCES, INC. payments to acquire property, plant, and equipment for fiscal 2020 was $204.00K.
Period endPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 6 monthPayments to Acquire Property, Plant, and Equipment 9 monthPayments to Acquire Property, Plant, and Equipment 12 month
2023-03-31$530.00K
10-Q · filed 2023-05-09
$899.00K
derived: sum of 2 quarters · filed 2023-05-09
$1.39M
derived: sum of 3 quarters · filed 2023-05-09
$2.28M
derived: sum of 4 quarters · filed 2023-05-09
2022-12-31$369.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$860.00K
derived: sum of 2 quarters · filed 2023-02-28
$1.75M
derived: sum of 3 quarters · filed 2023-02-28
$2.70M
10-K · filed 2023-02-28
2022-09-30$491.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$1.38M
derived: sum of 2 quarters · filed 2022-11-09
$2.33M
10-Q · filed 2022-11-09
$2.52M
derived: sum of 4 quarters · filed 2023-05-09
2022-06-30$888.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
$1.84M
10-Q · filed 2022-08-11
$2.03M
derived: sum of 3 quarters · filed 2023-05-09
$2.40M
derived: sum of 4 quarters · filed 2023-05-09
2022-03-31$955.00K
10-Q · filed 2023-05-09
$1.15M
derived: sum of 2 quarters · filed 2023-05-09
$1.51M
derived: sum of 3 quarters · filed 2023-05-09
$1.79M
derived: sum of 4 quarters · filed 2023-05-09
2021-12-31$190.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$556.00K
derived: sum of 2 quarters · filed 2023-02-28
$838.00K
derived: sum of 3 quarters · filed 2023-02-28
$1.14M
10-K · filed 2023-02-28
2021-09-30$366.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$648.00K
derived: sum of 2 quarters · filed 2022-11-09
$946.00K
10-Q · filed 2022-11-09
$925.00K
derived: sum of 4 quarters · filed 2023-02-28
2021-06-30$282.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
$580.00K
10-Q · filed 2022-08-11
$559.00K
derived: sum of 3 quarters · filed 2023-02-28
$598.00K
derived: sum of 4 quarters · filed 2023-02-28
2021-03-31$298.00K
10-Q · filed 2022-05-12
$277.00K
derived: sum of 2 quarters · filed 2023-02-28
$316.00K
derived: sum of 3 quarters · filed 2023-02-28
$331.00K
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31-$21.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$18.00K
derived: sum of 2 quarters · filed 2023-02-28
$33.00K
derived: sum of 3 quarters · filed 2023-02-28
$204.00K
10-K · filed 2023-02-28
2020-09-30$39.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
$54.00K
derived: sum of 2 quarters · filed 2021-11-12
$225.00K
10-Q · filed 2021-11-12
2020-06-30$15.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11
$186.00K
10-Q · filed 2021-08-11
2020-03-31$171.00K
10-Q · filed 2021-05-13